Nevakar Injectables - Six Development-Stage Product - Ownership and Business Overview

Life ScienceCompany

Nevakar Injectables - Six Development-Stage Product Ownership

Who owns Nevakar Injectables - Six Development-Stage Product?

Nevakar Injectables - Six Development-Stage Product is owned by Endo International. It was acquired on May 2, 2022.

Nevakar Injectables - Six Development-Stage Product Business Overview

Where is Nevakar Injectables - Six Development-Stage Product headquartered?

Nevakar Injectables - Six Development-Stage Product is headquartered in Bridgewater, New Jersey.

What sector is Nevakar Injectables - Six Development-Stage Product in?

Nevakar Injectables - Six Development-Stage Product is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 288 acquisitions of life science companies in 2022, including 35 acquisitions by private equity firms, and 253 by strategics.

Nevakar Injectables - Six Development-Stage Product

Bridgewater, New Jersey
United States,

Nevakar Injectables' Six Development-Stage Product Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration.


 Subscribe to unlock this and 202,135
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.